We are a leading manufacturer and supplier of pharmaceutical intermediates and fine chemicals, dedicated to delivering high-quality products and exceptional service to our global clientele.
Pharmaceutical intermediates are the crucial precursors used in the synthesis of active pharmaceutical ingredients (APIs). These compounds play a vital role in ensuring the quality, efficiency, and cost-effectiveness of drug manufacturing. what is pharmaceutical intermediates
Our expertise in complex organic chemistry and process development allows us to deliver high-quality intermediates with consistent purity and reliable supply. We leverage cutting-edge technologies and stringent quality control measures to meet the evolving needs of the pharmaceutical industry.
We are built on a foundation of technical expertise, innovation, and a commitment to quality.
Expertise in multi-step organic synthesis, complex reactions, and chiral chemistry.
Scalable and robust manufacturing processes for consistent product quality and cost-effectiveness.
Rigorous analytical testing and quality assurance protocols to ensure product integrity and compliance.
Data-driven insights into our operational efficiency and product quality.
Below is a representative sample of our product specifications.
| Parameter | Specification | Test Method | CAS Number | Molecular Formula | Molecular Weight |
|---|---|---|---|---|---|
| Appearance | White to Off-White Powder | Visual Inspection | 1234-56-7 | C10H12O3 | 180.20 g/mol |
| Purity (HPLC) | ≥ 98.0% | HPLC | 9876-54-3 | C12H14O4 | 222.24 g/mol |
| Water Content (KF) | ≤ 0.5% | Karl Fischer Titration | 6543-21-0 | C8H10O2 | 138.17 g/mol |
| Residue on Ignition | ≤ 0.1% | Sulphated Ash | 2345-67-8 | C6H8O | 100.13 g/mol |
| Heavy Metals | ≤ 10 ppm | ICP-MS | 8765-43-2 | C5H6O2 | 98.09 g/mol |
| Melting Point | 80-85 °C | Capillary Method | 5432-10-9 | C4H6O | 70.09 g/mol |
| Assay (GC) | ≥ 99.5% | Gas Chromatography | 1234-56-7 | C3H6O | 58.08 g/mol |
Note: These specifications are representative and may vary based on specific product requirements. Please contact us for a detailed Certificate of Analysis (CoA) for each batch.
Delivering tailored solutions to meet our customers’ unique needs.
Successfully synthesized a complex API with high purity and yield, enabling a client to initiate Phase I clinical trials.
Successfully scaled up the production of a critical intermediate, meeting stringent quality and volume requirements for a large-scale clinical trial.
Expert answers to common technical and commercial inquiries.
Partner with us for high-quality intermediates and dedicated support to accelerate your drug development programs. Let's build a healthier future together!